UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...

Okanagan Clinical Trials is offering new opportunities for people to participate in important clinical research studies ...

Early-onset Alzheimer's, affecting individuals under 65, presents unique challenges with memory, thinking, and daily ...

Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation ...

New program combines IV-delivered TRACER™ capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

The model reveals that more connected brain regions are more prone to damage, while isolated areas remain resilient. This approach offers a powerful framework for understanding disease progression and ...

Lexington, Massachusetts Tuesday, July 22, 2025, 18:00 Hrs [IST] ...

Roche has obtained European approval for a blood test to help rule out Alzheimer’s disease, allowing patients to avoid ...

Newborns and individuals with Alzheimer's disease have been found to share an unusual biological feature: both show high ...

Sleep and brain experts respond to new findings on the association between REM sleep and Alzheimer's disease, recommending consistent sleep habits and early intervention.